Literature DB >> 28073895

Evaluation of Genotypic and Phenotypic Methods to Detect Carbapenemase Production in Gram-Negative Bacilli.

Allison R McMullen1, Melanie L Yarbrough1, Meghan A Wallace1, Angela Shupe1, Carey-Ann D Burnham2.   

Abstract

BACKGROUND: Carbapenemase-producing gram-negative bacteria (CP-GNB) are an urgent and expanding public health threat. Rapid and accurate identification of these organisms facilitates infection prevention efforts in healthcare facilities. The objective of our study was to evaluate methods to detect and identify CP-GNB.
METHODS: We examined 189 carbapenem-resistant GNB(CR-GNB), including Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii complex, using 3 different methods: 2 methods to screen isolates of GNB for carbapenemase production [the carbapenem inactivation method (CIM) and 2 chromogenic agars] and a molecular method (Cepheid GeneXpert Carba-R) to identify the mechanism of carbapenem resistance and the associated resistance genes (blaKPC, blaNDM, blaIMP, blaOXA-48-like, and blaVIM).
RESULTS: The CIM was a simple and inexpensive phenotypic screen to differentiate between CR-GNB and CP-GNB, with improved analytical performance characteristics and inter-reader correlation compared to the modified Hodge test. Both chromogenic agars evaluated (HardyCHROM CRE and chromID CARBA) were able to support growth of most of the organisms tested, including isolates possessing the blaOXA-48-like gene. However, these media had a low analytical specificity for carbapenemase production, with breakthrough of CR-GNB that did not produce a carbapenemase. The Xpert Carba-R assay was rapid and easy to perform, and demonstrated 100% positive and negative agreement for characterization of genetic determinants of carbapenem resistance.
CONCLUSIONS: Screening by CIM followed by the Xpert Carba-R PCR is an accurate method for detecting and characterizing CP-GNB, including Enterobacteriaceae, P. aeruginosa, and A. baumannii complex.
© 2016 American Association for Clinical Chemistry.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28073895     DOI: 10.1373/clinchem.2016.264804

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  13 in total

1.  Multicenter Evaluation of the Xpert Carba-R Assay for Detection and Identification of Carbapenemase Genes in Sputum Specimens.

Authors:  Zhen Cai; Jia Tao; Tianye Jia; Hongyu Fu; Xin Zhang; Mei Zhao; Hong Du; Hua Yu; Bin Shan; Bin Huang; Liang Chen; Yi-Wei Tang; Wei Jia; Fen Qu
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

Review 2.  From the Pipeline to the Bedside: Advances and Challenges in Clinical Metagenomics.

Authors:  Augusto Dulanto Chiang; John P Dekker
Journal:  J Infect Dis       Date:  2020-03-28       Impact factor: 5.226

3.  Evaluation of a Modified Carbapenem Inactivation Method for Detection of Carbapenemases in Pseudomonas aeruginosa.

Authors:  Luiz F Lisboa; LeeAnn Turnbull; David A Boyd; Michael R Mulvey; Tanis C Dingle
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

4.  Breakpoint beware: reliance on historical breakpoints for Enterobacteriaceae leads to discrepancies in interpretation of susceptibility testing for carbapenems and cephalosporins and gaps in detection of carbapenem-resistant organisms.

Authors:  Melanie L Yarbrough; Meghan A Wallace; Robert F Potter; Alaric W D'Souza; Gautam Dantas; Carey-Ann D Burnham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-02       Impact factor: 3.267

5.  Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: Shifting burden of disease?

Authors:  Nicholas S Britt; David J Ritchie; Marin H Kollef; Carey-Ann D Burnham; Michael J Durkin; Nicholas B Hampton; Scott T Micek
Journal:  Am J Infect Control       Date:  2018-04-26       Impact factor: 2.918

Review 6.  How to manage Pseudomonas aeruginosa infections.

Authors:  Matteo Bassetti; Antonio Vena; Antony Croxatto; Elda Righi; Benoit Guery
Journal:  Drugs Context       Date:  2018-05-29

Review 7.  The threat of carbapenem-resistant gram-negative bacteria in a Middle East region.

Authors:  Effat Davoudi-Monfared; Hossein Khalili
Journal:  Infect Drug Resist       Date:  2018-10-17       Impact factor: 4.003

8.  Carbapenemase-producing Enterobacteriaceae circulating in the Reunion Island, a French territory in the Southwest Indian Ocean.

Authors:  Guillaume Miltgen; Pascal Cholley; Daniel Martak; Michelle Thouverez; Paul Seraphin; Alexandre Leclaire; Nicolas Traversier; Bénédicte Roquebert; Marie-Christine Jaffar-Bandjee; Nathalie Lugagne; Céline Ben Cimon; Mahery Ramiandrisoa; Sandrine Picot; Anne Lignereux; Geoffrey Masson; Jérôme Allyn; Nicolas Allou; Patrick Mavingui; Olivier Belmonte; Xavier Bertrand; Didier Hocquet
Journal:  Antimicrob Resist Infect Control       Date:  2020-02-19       Impact factor: 4.887

9.  Evaluation of the Revogene Carba C Assay for Detection and Differentiation of Carbapenemase-Producing Gram-Negative Bacteria.

Authors:  Delphine Girlich; Marine Laguide; Laurent Dortet; Thierry Naas
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

10.  Draft Genome Sequence of the blaOXA-436- and blaNDM-1-Harboring Shewanella putrefaciens SA70 Isolate.

Authors:  Robert F Potter; Alaric W D'Souza; Meghan A Wallace; Angela Shupe; Sanket Patel; Danish Gul; Jennie H Kwon; Saadia Andleeb; C A Burnham; Gautam Dantas
Journal:  Genome Announc       Date:  2017-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.